# Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

> **NCT06952517** · PHASE2 · RECRUITING · sponsor: **Narrows Institute for Biomedical Research** · enrollment: 20 (estimated)

## Conditions studied

- Papular-pustular Rosacea
- Papulopustular Rosacea (PPR)
- Papulopustular Rosacea

## Interventions

- **DRUG:** Clascoterone Cream 1%

## Key facts

- **NCT ID:** NCT06952517
- **Lead sponsor:** Narrows Institute for Biomedical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-14
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952517, "Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06952517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*